2019. Experimental Approaches to the Assessment of Potential Cardioprotective Means with Doxorubicin-Associated Cardiomyopathy. Asian Journal of Pharmaceutics (AJP). 12, 04 (Feb. 2019). DOI:https://doi.org/10.22377/ajp.v12i04.2943.